MedPath

A New Method of Surgically Treating Varicose Veins and Venous Ulcers - a Study to Assess Clinical and Economic Value

Not Applicable
Completed
Conditions
Varicose Veins
Venous Insufficiency
Venous Ulceration
Interventions
Procedure: Surgery - Saphenofemoral ligation, saphenous strip and avulsions
Procedure: EVLT
Registration Number
NCT00759434
Lead Sponsor
Hull University Teaching Hospitals NHS Trust
Brief Summary

Varicose veins are a common problem, affecting up to a third of the western adult population. Most suffer with aching, discomfort, pruritis, and muscle cramps, whilst complications include oedema, eczema, lipodermatosclerosis, ulceration, phlebitis, and bleeding. This is known to have a significant negative effect on patient's quality of life (QoL).

Surgery has been used for many years, but it is known that there is a temporary decline in QoL post-op. This was demonstrated in our pilot study. Surgery leads to painful and prolonged recovery in some patients and has the risks of infection, haematoma and nerve injury.

Recurrence rates are known to be significant. Duplex of veins post surgery has demonstrated persistent reflux in 9-29% of cases at 1 year, 13-40% at 2 years, 40% at 5 years and 60% at 34 years.

26% of NHS patients were 'very dissatisfied' with their varicose vein surgery.

Newer, less invasive treatments are being developed. It would be advantageous to find a treatment that avoided the morbidity of surgery, one that could be performed as a day-case procedure under a local anaesthetic, a treatment that could offer lower recurrence rates and allow an early return to work. These should be the aims of any new treatment for varicose veins.

Endovenous Laser Treatment (EVLT) is performed under a local anaesthetic and uses laser energy delivered into the vein to obliterate it. The vein therefore need not be tied off surgically and stripped out.

The aim of this study is to compare the clinical, cost effectiveness and safety of Surgery and EVLT.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
280
Inclusion Criteria
  • Primary, symptomatic, varicose veins.
  • Isolated Saphenofemoral junction (SFJ) incompetence leading to long saphenous (LSV) reflux on duplex ultrasound.
  • LSV of 4mm diameter at the knee.
  • Ability to give informed written consent.
Exclusion Criteria
  • Inability to give informed written consent.
  • Symptomatic or complicated varicose veins not attributable to SFJ/LSV reflux.
  • Evidence of deep venous reflux on duplex scan.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SurgerySurgery - Saphenofemoral ligation, saphenous strip and avulsions-
EVLTEVLT-
Primary Outcome Measures
NameTimeMethod
Generic Quality of life - Short Form-361 week, 6 weeks, 3 months, 1 year, 2 years
Secondary Outcome Measures
NameTimeMethod
Generic quality of life - EuroQol1 week, 6 weeks, 3 months, 1 year, 2 years
Disease Specific quality of life - Aberdeen Varicose Vein Questionnaire1 week, 6 weeks, 3 months, 1 year, 2 years
Venous Clinical Severity Score3 months, 1 year, 2 years
Would undergo EVLT again if necessary1 week, 6 weeks, 3 months, 1 year, 2 years
Complication rates1 week, 6 weeks, 3 months, 1 year, 2 years
Return to work and normal functioning1 week, 6 weeks
Cost Effectiveness2 years
Visual analogue pain scores1 week
Duplex and clinical assessment1 week, 6 weeks, 3 months, 1 year, 2 years

A detailed clinical and duplex ultrasound assessment was undertaken to identify:

The presence of residual or recurrent varicose veins (defined as clinically evident varicose veins of greater than 3mm in diameter present at 1 and 6 weeks (residual) or becoming evident only after 6 weeks (recurrent). This was irrespective of the presence or absence of symptoms.

The pattern of underlying insufficiency on duplex giving rise to any clinically evident varicose veins or skin changes.

Trial Locations

Locations (1)

Hull Royal Infirmary

🇬🇧

Hull, East Yorkshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath